berberine has been researched along with Coronary Disease in 2 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine (BBR) is an isoquinoline alkaloid found in the Berberis species." | 5.72 | Effect of berberine on global modulation of lncRNAs and mRNAs expression profiles in patients with stable coronary heart disease. ( Han, YC; Li, JY; Lu, B; Qian, H; Xiang, RL; Xie, HZ; Zhang, SY, 2022) |
| "Berberine (BBR) is an isoquinoline alkaloid found in the Berberis species." | 1.72 | Effect of berberine on global modulation of lncRNAs and mRNAs expression profiles in patients with stable coronary heart disease. ( Han, YC; Li, JY; Lu, B; Qian, H; Xiang, RL; Xie, HZ; Zhang, SY, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YC | 1 |
| Xie, HZ | 1 |
| Lu, B | 1 |
| Xiang, RL | 1 |
| Li, JY | 1 |
| Qian, H | 1 |
| Zhang, SY | 1 |
| Li, C | 1 |
| Hu, Z | 1 |
| Zhang, W | 1 |
| Yu, J | 1 |
| Yang, Y | 1 |
| Xu, Z | 1 |
| Luo, H | 1 |
| Liu, X | 1 |
| Liu, Y | 1 |
| Chen, C | 1 |
| Cai, Y | 1 |
| Xia, X | 1 |
| Zhang, X | 1 |
| Wang, DZ | 1 |
| Wu, G | 1 |
| Zeng, C | 1 |
2 other studies available for berberine and Coronary Disease
| Article | Year |
|---|---|
Effect of berberine on global modulation of lncRNAs and mRNAs expression profiles in patients with stable coronary heart disease.
Topics: Berberine; Coronary Disease; Estrogen Receptor alpha; Humans; Mitogen-Activated Protein Kinases; RNA | 2022 |
Regulation of Cholesterol Homeostasis by a Novel Long Non-coding RNA LASER.
Topics: Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Benzoates; Benzylamines; Berberine; Cholest | 2019 |